Proposal for the delineation of postoperative primary clinical target volumes in ethmoid cancers
Copyright © 2020. Published by Elsevier Masson SAS..
It is proposed to delineate the anatomo-clinical target volumes of primary tumor (CTV-P) in ethmoid cancers treated with post-operative radiotherapy. This concept is based on the use of radioanatomy and the natural history of cancer. It is supported by the repositioning of the planning scanner with preoperative imaging for the replacement of the initial GTV and the creation of margins around it extended to the microscopic risk zones according to the anatomical concept. This article does not discuss the indications of external radiotherapy but specifies the volumes to be delineated if radiotherapy is considered.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:25 |
|---|---|
| Enthalten in: |
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique - 25(2021), 2 vom: 02. Apr., Seite 200-205 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
Proposition de délinéation des volumes cibles anatomocliniques postopératoires de la tumeur primitive des cancers de l’ethmoïde |
|---|
| Beteiligte Personen: |
Guillemin, F [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cancer |
|---|
| Anmerkungen: |
Date Completed 02.04.2021 Date Revised 02.04.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.canrad.2020.04.015 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM321075544 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM321075544 | ||
| 003 | DE-627 | ||
| 005 | 20231225175036.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.canrad.2020.04.015 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1070.xml |
| 035 | |a (DE-627)NLM321075544 | ||
| 035 | |a (NLM)33546996 | ||
| 035 | |a (PII)S1278-3218(20)30312-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Guillemin, F |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Proposal for the delineation of postoperative primary clinical target volumes in ethmoid cancers |
| 246 | 3 | 3 | |a Proposition de délinéation des volumes cibles anatomocliniques postopératoires de la tumeur primitive des cancers de l’ethmoïde |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.04.2021 | ||
| 500 | |a Date Revised 02.04.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020. Published by Elsevier Masson SAS. | ||
| 520 | |a It is proposed to delineate the anatomo-clinical target volumes of primary tumor (CTV-P) in ethmoid cancers treated with post-operative radiotherapy. This concept is based on the use of radioanatomy and the natural history of cancer. It is supported by the repositioning of the planning scanner with preoperative imaging for the replacement of the initial GTV and the creation of margins around it extended to the microscopic risk zones according to the anatomical concept. This article does not discuss the indications of external radiotherapy but specifies the volumes to be delineated if radiotherapy is considered | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Practice Guideline | |
| 650 | 4 | |a Cancer | |
| 650 | 4 | |a Clinical target volumes | |
| 650 | 4 | |a Delineation | |
| 650 | 4 | |a Ethmoid | |
| 650 | 4 | |a Ethmoïde | |
| 650 | 4 | |a Radiotherapy | |
| 650 | 4 | |a Radiothérapie | |
| 650 | 4 | |a Volume cible anatomo-clinique (CTV) | |
| 650 | 4 | |a délinéation | |
| 700 | 1 | |a Miroir, J |e verfasserin |4 aut | |
| 700 | 1 | |a Piram, L |e verfasserin |4 aut | |
| 700 | 1 | |a Bellini, R |e verfasserin |4 aut | |
| 700 | 1 | |a Saroul, N |e verfasserin |4 aut | |
| 700 | 1 | |a Pham Dang, N |e verfasserin |4 aut | |
| 700 | 1 | |a Boisselier, P |e verfasserin |4 aut | |
| 700 | 1 | |a Bourhis, J |e verfasserin |4 aut | |
| 700 | 1 | |a Calugaru, V |e verfasserin |4 aut | |
| 700 | 1 | |a Coutte, A |e verfasserin |4 aut | |
| 700 | 1 | |a Graff, P |e verfasserin |4 aut | |
| 700 | 1 | |a Pointreau, Y |e verfasserin |4 aut | |
| 700 | 1 | |a Racadot, S |e verfasserin |4 aut | |
| 700 | 1 | |a Sun, X S |e verfasserin |4 aut | |
| 700 | 1 | |a Thariat, J |e verfasserin |4 aut | |
| 700 | 1 | |a Biau, J |e verfasserin |4 aut | |
| 700 | 1 | |a Lapeyre, M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique |d 1998 |g 25(2021), 2 vom: 02. Apr., Seite 200-205 |w (DE-627)NLM092193420 |x 1769-6658 |7 nnns |
| 773 | 1 | 8 | |g volume:25 |g year:2021 |g number:2 |g day:02 |g month:04 |g pages:200-205 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.canrad.2020.04.015 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 25 |j 2021 |e 2 |b 02 |c 04 |h 200-205 | ||